Corcept Therapeutics, Inc. (CORT)
116.23
+2.20
(+1.93%)
USD |
NASDAQ |
Oct 02, 16:00
116.23
0.00 (0.00%)
After-Hours: 20:00
Corcept Therapeutics Price to Book Value : 17.77 for Oct. 2, 2026
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| October 02, 2026 | 17.77 |
| October 01, 2026 | 17.44 |
| September 30, 2026 | 17.62 |
| September 29, 2026 | 17.54 |
| September 28, 2026 | 17.68 |
| September 25, 2026 | 17.75 |
| September 24, 2026 | 18.12 |
| September 23, 2026 | 17.27 |
| September 22, 2026 | 17.97 |
| September 21, 2026 | 17.40 |
| September 18, 2026 | 16.86 |
| September 17, 2026 | 17.56 |
| September 16, 2026 | 17.10 |
| September 15, 2026 | 16.95 |
| September 14, 2026 | 17.10 |
| September 11, 2026 | 17.25 |
| September 10, 2026 | 17.57 |
| September 09, 2026 | 17.69 |
| September 08, 2026 | 17.43 |
| September 04, 2026 | 17.07 |
| September 03, 2026 | 17.25 |
| September 02, 2026 | 16.89 |
| September 01, 2026 | 17.34 |
| August 31, 2026 | 17.33 |
| August 28, 2026 | 17.41 |
| Date | Value |
|---|---|
| August 27, 2026 | 17.88 |
| August 26, 2026 | 18.32 |
| August 25, 2026 | 18.90 |
| August 24, 2026 | 18.84 |
| August 21, 2026 | 18.69 |
| August 20, 2026 | 18.51 |
| August 19, 2026 | 18.20 |
| August 18, 2026 | 18.06 |
| August 17, 2026 | 17.92 |
| August 14, 2026 | 17.50 |
| August 13, 2026 | 16.90 |
| August 12, 2026 | 17.15 |
| August 11, 2026 | 17.10 |
| August 10, 2026 | 17.47 |
| August 07, 2026 | 16.94 |
| August 06, 2026 | 16.51 |
| August 05, 2026 | 16.93 |
| August 04, 2026 | 16.79 |
| August 03, 2026 | 17.25 |
| July 31, 2026 | 17.51 |
| July 30, 2026 | 18.09 |
| July 29, 2026 | 14.21 |
| July 28, 2026 | 14.40 |
| July 27, 2026 | 13.93 |
| July 24, 2026 | 14.58 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price to Book Value Benchmarks
| Eli Lilly & Co. | 31.76 |
| Pfizer Inc. | 1.860 |
| Aclaris Therapeutics, Inc. | 4.927 |
| Bristol Myers Squibb Co. | 5.597 |
| Liquidia Corp. | 13.08 |
Price to Book Value Related Metrics
| PE Ratio | 277.60 |
| PS Ratio | 16.16 |
| Price to Free Cash Flow | 125.59 |
| Price | 116.23 |
| Earnings Yield | 0.36% |
| Market Cap | 12.54B |
| Operating PE Ratio | 2096.47 |
| Normalized PE Ratio | 277.60 |